This
article it is about a new combination of treatment ageing Congenital Measles, This
was written by Yasemin Ozsurekci et al on December 7, 2014. She presents a
research of two cases from Turkey, using this king of treatment.
At
the beginning, this article speaks about the epidemiology of the measles
infection; The author make emphasis in the risk of this infection in pregnancy
women and the side effect on the babies.
Then
explain that the regular treatment in a pregnancy woman usually is with
immunoglobulin prophylax. For this research they chose two preterm babies, who
get infected at the epidemic in Turkey (2012 to 2013), and they used the
combination of Immunoglobulin and vitamin A.
At
the article, the author shows an image abut the monitoring of both patients and
the results.
Then
explain all the clinic history about the two cases: The first case, it was a
pregnancy woman who does not have the measles vaccine and she gets infected,
and suffer Pneumonia ass a measles complication. And the second case, it was about
a pregnancy woman, who only received one shot of the vaccine, and se get
infected to, but she only suffers Pneumonitis.
Both
cases had premature babies, without showing symptoms of the infection.
At
the time, he was explained what king of lab test he used on the babies and
their mothers, and what the results of that test were, after used the double
treatment.
An
at the end, the author wrote about the importance of the vaccination programs
in all of children, and how this can increase the immunity protection when
their mother gives them some part of the immunity. But the most important about
this research is if it were to present a case of measles, an effective
treatment it might great with the combination of immunoglobulin and vitamin A.
Marina,
ResponderEliminarVery good summary. I think that you know that we now have a problem with measles here in the USA now. Some people have died. It happened at Disneyland in California. Some people in the USA don't believe that getting the vaccine is important.